However, our results revealed that phospho-activation of the PI3K and EGFR pathways by LRIG2 contributes to inhibition of endometrial tumor growth, implying a non-canonical role for PI3K/AKT in opposing cell survival and proliferation. Here, AKT1 is linked to endometrium neoplasm.